We found a significant accumulation of CD103+ cells in tumor metastases compared to their corresponding primary tumor (p = 0.032, Figure 2, Table 4), whereas the numbers of the other immune cells were significantly lower in tumor metastases compared to their primary tumor (Table 4). The gene discussed is ITGAE; the disease is neoplasm.